GLP-1 helps control blood sugar by improving insulin sensitivity and reducing appetite, GIP helps insulin secretion and fat metabolism
This makes intramuscular shots the better option for patients who need quick results or to treat severe deficiencies
This function is particularly beneficial for PCOS patients, as research indicates that almost 80% of treated patients showed improved insulin resistance markers, even in cases where significant weight loss wasn't achieved
by transplanting fecal communities from clinically verified responder or non-responder human phenotypes into germ-free rodent models, investigators can systematically isolate and verify the causal contribution of specific microbial configurations to incretin drug efficacy
However, GLP-/GIP dual agonists have been proved to be orally effective in animal experiments, and its state in plasma is more stable than GLP-1RA [141], and this oral administration method has gradually been applied to the clinic [142]
This guide breaks down the science behind GLP-1 non-response, explains why tirzepatide often succeeds where semaglutide fails, walks you through the switching process step by step, and helps you set realistic expectations for what happens next